Ñî¹óåú´«Ã½

Start main page content

Q&A with Professor Shabir Madhi

Madhi is Professor of Vaccinology at Ñî¹óåú´«Ã½ University, the Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA), and leads the South African Ox1Cov-19 Vaccine VIDA-Trial.

Question: Why is there a need for a Covid 19 vaccine?
Question: Why do the trials in South Africa?
Question: Who developed, licensed and produces the vaccine?
When will the vaccine be available?
Question: Can you get infected with the Covid-19 vaccine?
Question: What are the timelines of the study and the development of the vaccine?
Question: What is the process of doing a clinical trial on a Covid 19 vaccine?
Question: Where do we stand in terms of a viable Covid 19 vaccine in SA?
Question: How are the participants selected for the study?
Question: How are the participants of the study protected?
Question: How are the participants of the study protected?
Question: Is this the new normal?
Question: Where do we stand in terms of a viable Covid 19 vaccine globally?
Question: How will the Covid 19 pandemic develop with or without the vaccine?
Question: What lessons can we learn from Covid 19?
Share